Background
In patients with coronavirus disease (COVID‐19) due to severe acute respiratory syndrome coronavirus 2 infection, pneumomediastinum has been increasingly reported in cases of noninvasive oxygen therapy, including high‐flow nasal cannula, and invasive mechanical ventilation. However, its pathogenesis is still not understood.
Case Presentation
We report two cases of pneumomediastinum in acute respiratory distress syndrome (ARDS) caused by COVID‐19. In both cases, control of spontaneous breathing with neuromuscular blocking agents resulted in resolution of pneumoperitoneum.
Conclusion
The improvement of pneumomediastinum with control of spontaneous breathing suggested patient self‐inflicted lung injury as a possible mechanism in this case series. In ARDS cases with pneumomediastinum, in addition to controlling plateau pressure with conventional lung protective ventilation, spontaneous breathing should be controlled if the patient’s inspiratory effort is suspected to be strong.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.